Mesenchymal stem cells attenuate rat graft-versus-host disease

Masayuki Fujino1, Ping Zhu, Yusuke Kitazawa

  • 1Division of Transplantation Immunology, National Research Institute for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo, 157-8535, Japan.

Summary

Mesenchymal stem cells (MSCs) show potential in treating T cell diseases. However, cloned MSCs unexpectedly enhanced T cell proliferation and did not improve graft-versus-host disease (GvHD) in a rat model.